CRIS
Curis, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.35
−1.46%Margins
Gross margin
99.3%
EBITDA margin
-506.2%
EBIT margin
-833.4%
Net margin
-490.3%
FCF margin
-709.0%
-450.5%
Return on equity
-111.5%
Return on assets
-626.5%
Return on invested capital
0.18x
Asset turnover
-$30.6M
Cash from operations
$2.32
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026